THC
19.2–22.8%
CBD
0.2%
Romulan x Ubc Chemo is a hybrid with a plainly stated two-parent lineage and a THC range of 19.2 to 22.8 percent.
No effect, terpene, flavor or medical-use data specific to Romulan x Ubc Chemo has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
22.8% THC
About Romulan x Ubc Chemo
Combining Romulan with UBC Chemo puts two named lines together under a plain cross-name rather than a stylized title, and the result is classified as a hybrid rather than leaning to either side. THC lands between 19.2 and 22.8 percent, a solidly upper-mid range that outpaces a lot of standard-shelf flower. That two-parent lineage is spelled out directly in the name itself, which stands out next to strains that hide their parentage behind branding rather than stating it outright. A hybrid built from two named parents and finishing just under 23 percent THC sits toward the stronger end of what shoppers browsing by potency tend to favor, a straightforward pairing without any embellishment attached to how it's marketed.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Romulan x Ubc Chemo
Is Romulan x Ubc Chemo an Indica, Sativa, or Hybrid?
Romulan x Ubc Chemo is classified as a hybrid cannabis strain bred from a genetic cross of Romulan × Ubc Chemo.
What cannabinoid content is reported for Romulan x Ubc Chemo?
Romulan x Ubc Chemo: 22.8% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.